Hepatitis B News and Research

Latest Hepatitis B News and Research

Australia leads the world in childhood immunization coverage

Even as Australia reels under a deadly flu season, some solace may be found in the fact that almost 95% of of five-year-old Australian children are almost completely immunized against deadly childhood diseases, according to the latest report.

8 Jul 2019

Number of fully-immunized Australian kids hits record high

New data for the March quarter in 2019 revealed the immunization rates for all five-year-old children in the country increased to 94.78 percent from the previous record of 94.67 percent in December 2018.

7 Jul 2019

New statement lays down recommendations to combat fall in vaccination rates

Search engines and social media organizations must do more to prevent the spread of inaccurate information on childhood vaccination, and governments must better support mandatory immunization programs, says an international group of leading public health scientists in a statement published in the Journal of Health Communication.

2 Jul 2019

Europe: Data shows upward trend in chronic hepatitis B cases since 2008

In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.

21 Jun 2019

Researcher employs people who inject drugs to study factors influencing acquisition of HIV

In recent years, the HIV infection rate in Estonia has continued to be around 200 new cases each year, which is still one of the highest incidence rates per 100,000 inhabitants in Europe.

20 Jun 2019

Researchers succeed in conquering chronic infection with hepatitis B virus

Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

11 Jun 2019

Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

"Green revolution" in the early 1950s, the extensive cultivation of Dwarf Rice solves the food problem in developing countries. At present, chronic infection with hepatitis B virus (HBV) has been a major public health problem.

11 Jun 2019

Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and death

Receiving a blood transfusion during curative surgery for the most common type of liver cancer is associated with a much higher risk of cancer recurrence and dying prematurely, according to new research being presented at this year's Euroanaesthesia congress in Vienna, Austria

3 Jun 2019

Researchers map bone-marrow microenvironment to shed new light on leukemia

Stem cells are surrounded and protected by the stem-cell niche - the microenvironment - of the tissue in which they are found.

24 May 2019

Adult-onset inflammatory bowel disease tied to higher mortality

While the onset of inflammatory bowel disease (ulcerative colitis or Crohn's disease) in adulthood is tied to a higher mortality, the actual number of deaths has been falling, a Swedish study from Karolinska Institutet published in the journal Gut reports.

17 May 2019

Researchers describe the impact of chronic hepatitis D on parts of the immune system

Approximately one out of every ten people with hepatitis B are coinfected with hepatitis D, which is among the most serious liver conditions.

15 May 2019

Developing effective needleless vaccine to protect children from dangerous viruses

Millions of people are infected with hepatitis B every year. Hundreds of thousands die. And small children are particularly at risk.

3 May 2019

Scientific evidence for and against causal associations for 47 adverse effects after immunization

A new systematic review provides a succinct summary of the scientific evidence for and/or against causal associations for 47 adverse events following immunization.

29 Apr 2019

Researchers examine the barriers to vaccination in immunocompromised children

A new study examines the barriers to vaccination of immunocompromised children. Findings from the study will be presented during the Pediatric Academic Societies 2019 Meeting, taking place on April 24 - May 1 in Baltimore.

27 Apr 2019

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Research sheds light on how hepatitis B virus establishes chronic infection

New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao Guo of the Indiana University School of Medicine, Bin Wang and Jiming Zhang of Fudan University, and colleagues.

19 Apr 2019

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

17 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

Hepatitis B News and Research

Latest Hepatitis B News and Research

Australia leads the world in childhood immunization coverage

Number of fully-immunized Australian kids hits record high

New statement lays down recommendations to combat fall in vaccination rates

Europe: Data shows upward trend in chronic hepatitis B cases since 2008

Researcher employs people who inject drugs to study factors influencing acquisition of HIV

Researchers succeed in conquering chronic infection with hepatitis B virus

Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

Receiving blood transfusion during liver cancer surgery has higher risk of recurrence and death

Researchers map bone-marrow microenvironment to shed new light on leukemia

Adult-onset inflammatory bowel disease tied to higher mortality

Researchers describe the impact of chronic hepatitis D on parts of the immune system

Developing effective needleless vaccine to protect children from dangerous viruses

Scientific evidence for and against causal associations for 47 adverse effects after immunization

Researchers examine the barriers to vaccination in immunocompromised children

Key research takeaways from ECCMID 2019

Research sheds light on how hepatitis B virus establishes chronic infection

Innate immune sensor responding to gut microbes can suppress liver cancer

New study provides overview of potential risks of vaccinating breastfeeding women

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

Measuring the binding of SARS-CoV-2 Antibodies to the COVID Spike Protein using SPR

Identifying the Starting Points for COVID-19 Treatment

Improving IVF Treatments by Imaging Sperm Cells

Hepatitis B News and Research

Latest Hepatitis B News and Research

Newsletters you may be interested in